FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W3137347651> ?p ?o ?g. }

• W3137347651 abstract "People with post-stroke aphasia commonly receive speech-language therapy (SLT) when they are admitted to hospitals. Commonly, these patients reported communication difficulties in in-patient settings. Augmentative and alternative communication (AAC) has been reported as an effective treatment approach to improve communication effectiveness, language performance, decreasing depression, and improving quality of life for this population. However, little evidence has demonstrated the use of AAC intervention (AACT) in early recovery from people with post-stroke aphasia in in-patient rehabilitation settings for improving these patients' communication effectiveness. The pilot randomized controlled trial (RCT) will explore the effectiveness and feasibility of including AACT in regular SLT for in-patient people with post-stroke aphasia.This pilot RCT is a single-blind, randomized controlled trial with two parallel groups. Both groups receive a 1-h treatment session, including either both AACT and SLT or SLT only for ten consecutive days. We aim to include 22 in-patient participants with post-stroke aphasia in each group. Participants will be assessed at pre- and post-intervention and 2 weeks after intervention. The primary outcomes are the ability of communication measured by the communication of basic needs subtest in the Functional Assessment of Communication Skills for Adult (FACS) and the overall language performance measured by the Chinese Standard Aphasia Battery (ABC). The secondary outcomes include a 10-min conversation, the 10-item Hospital version of the Stroke Aphasic Depression Questionnaire (SADQH-10), the Stroke-Specific Quality of Life Scale (SS-QOL), and a patient and caregiver satisfaction questionnaire.This pilot RCT will contribute to new scientific evidence to the field of aphasia rehabilitation in early recovery during the in-patient period. The paper describes the trial, which will explore the effect of combining AACT and SLT and SLT only, our choice of primary and secondary outcome measures, and proposed analyses. The study results will provide information for implementing AACT in the regular in-patient SLT of future RCTs.Chinese Clinical Trial Registry database (ChiCTR) ChiCTR2000028870 . Registered on 5 January 2020." @default.
• W3137347651 created "2021-03-29" @default.
• W3137347651 creator A5003800208 @default.
• W3137347651 creator A5014864255 @default.
• W3137347651 creator A5016887977 @default.
• W3137347651 creator A5020485501 @default.
• W3137347651 creator A5028835481 @default.
• W3137347651 creator A5029377042 @default.
• W3137347651 creator A5039063082 @default.
• W3137347651 creator A5049010386 @default.
• W3137347651 creator A5056530881 @default.
• W3137347651 creator A5078112944 @default.
• W3137347651 creator A5091367277 @default.
• W3137347651 date "2021-11-24" @default.
• W3137347651 modified "2023-09-26" @default.
• W3137347651 title "Augmentative and alternative communication intervention for in-patient individuals with post-stroke aphasia: study protocol of a parallel-group, pragmatic randomized controlled trial" @default.
• W3137347651 cites W1891932247 @default.
• W3137347651 cites W1974399940 @default.
• W3137347651 cites W1991026952 @default.
• W3137347651 cites W1993542140 @default.
• W3137347651 cites W1995425807 @default.
• W3137347651 cites W2010201942 @default.
• W3137347651 cites W2017982719 @default.
• W3137347651 cites W2030505174 @default.
• W3137347651 cites W2037538089 @default.
• W3137347651 cites W2051059161 @default.
• W3137347651 cites W2064852826 @default.
• W3137347651 cites W2103844574 @default.
• W3137347651 cites W2128387141 @default.
• W3137347651 cites W2128672824 @default.
• W3137347651 cites W2142499410 @default.
• W3137347651 cites W2151560640 @default.
• W3137347651 cites W2313583115 @default.
• W3137347651 cites W2398463075 @default.
• W3137347651 cites W2513022183 @default.
• W3137347651 cites W2513740670 @default.
• W3137347651 cites W2605611487 @default.
• W3137347651 cites W2620743383 @default.
• W3137347651 cites W2750029871 @default.
• W3137347651 cites W2793783206 @default.
• W3137347651 cites W2795427419 @default.
• W3137347651 cites W2888222999 @default.
• W3137347651 cites W2918115922 @default.
• W3137347651 cites W3010300830 @default.
• W3137347651 doi "https://doi.org/10.1186/s13063-021-05799-0" @default.
• W3137347651 hasPubMedCentralId "https://www.ncbi.nlm.nih.gov/pmc/articles/8611624" @default.
• W3137347651 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/34819130" @default.
• W3137347651 hasPublicationYear "2021" @default.
• W3137347651 type Work @default.
• W3137347651 sameAs 3137347651 @default.
• W3137347651 citedByCount "1" @default.
• W3137347651 countsByYear W31373476512022 @default.
• W3137347651 crossrefType "journal-article" @default.
• W3137347651 hasAuthorship W3137347651A5003800208 @default.
• W3137347651 hasAuthorship W3137347651A5014864255 @default.
• W3137347651 hasAuthorship W3137347651A5016887977 @default.
• W3137347651 hasAuthorship W3137347651A5020485501 @default.
• W3137347651 hasAuthorship W3137347651A5028835481 @default.
• W3137347651 hasAuthorship W3137347651A5029377042 @default.
• W3137347651 hasAuthorship W3137347651A5039063082 @default.
• W3137347651 hasAuthorship W3137347651A5049010386 @default.
• W3137347651 hasAuthorship W3137347651A5056530881 @default.
• W3137347651 hasAuthorship W3137347651A5078112944 @default.
• W3137347651 hasAuthorship W3137347651A5091367277 @default.
• W3137347651 hasBestOaLocation W31373476511 @default.
• W3137347651 hasConcept C118552586 @default.
• W3137347651 hasConcept C127413603 @default.
• W3137347651 hasConcept C141071460 @default.
• W3137347651 hasConcept C159110408 @default.
• W3137347651 hasConcept C168563851 @default.
• W3137347651 hasConcept C1862650 @default.
• W3137347651 hasConcept C2778121785 @default.
• W3137347651 hasConcept C2779422653 @default.
• W3137347651 hasConcept C2779951463 @default.
• W3137347651 hasConcept C2780645631 @default.
• W3137347651 hasConcept C2780665704 @default.
• W3137347651 hasConcept C2908647359 @default.
• W3137347651 hasConcept C71924100 @default.
• W3137347651 hasConcept C78519656 @default.
• W3137347651 hasConcept C99454951 @default.
• W3137347651 hasConcept C99508421 @default.
• W3137347651 hasConceptScore W3137347651C118552586 @default.
• W3137347651 hasConceptScore W3137347651C127413603 @default.
• W3137347651 hasConceptScore W3137347651C141071460 @default.
• W3137347651 hasConceptScore W3137347651C159110408 @default.
• W3137347651 hasConceptScore W3137347651C168563851 @default.
• W3137347651 hasConceptScore W3137347651C1862650 @default.
• W3137347651 hasConceptScore W3137347651C2778121785 @default.
• W3137347651 hasConceptScore W3137347651C2779422653 @default.
• W3137347651 hasConceptScore W3137347651C2779951463 @default.
• W3137347651 hasConceptScore W3137347651C2780645631 @default.
• W3137347651 hasConceptScore W3137347651C2780665704 @default.
• W3137347651 hasConceptScore W3137347651C2908647359 @default.
• W3137347651 hasConceptScore W3137347651C71924100 @default.
• W3137347651 hasConceptScore W3137347651C78519656 @default.
• W3137347651 hasConceptScore W3137347651C99454951 @default.
• W3137347651 hasConceptScore W3137347651C99508421 @default.
• W3137347651 hasFunder F4320326704 @default.
• W3137347651 hasIssue "1" @default.
• W3137347651 hasLocation W31373476511 @default.

• next